| Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease E Sidransky, MA Nalls, JO Aasly, J Aharon-Peretz, G Annesi, ER Barbosa, ... New England Journal of Medicine 361 (17), 1651-1661, 2009 | 2243 | 2009 |
| Genome-wide association study reveals genetic risk underlying Parkinson's disease J Simon-Sanchez, C Schulte, JM Bras, M Sharma, JR Gibbs, D Berg, ... Nature genetics 41 (12), 1308-1312, 2009 | 2192 | 2009 |
| Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease MA Nalls, N Pankratz, CM Lill, CB Do, DG Hernandez, M Saad, ... Nature genetics 46 (9), 989-993, 2014 | 1993 | 2014 |
| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1558 | 2019 |
| Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ... The American Journal of Human Genetics 98 (3), 500-513, 2016 | 413 | 2016 |
| Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ... Proceedings of the National Academy of Sciences 111 (7), 2626-2631, 2014 | 381 | 2014 |
| Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ... Brain 140 (12), 3191-3203, 2017 | 376 | 2017 |
| Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease* D Berg, KJ Schweitzer, P Leitner, A Zimprich, P Lichtner, P Belcredi, ... Brain 128 (12), 3000-3011, 2005 | 322 | 2005 |
| SNCA variants are associated with increased risk for multiple system atrophy SW Scholz, H Houlden, C Schulte, M Sharma, A Li, D Berg, A Melchers, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 319 | 2009 |
| GBA-associated PD presents with nonmotor characteristics K Brockmann, K Srulijes, AK Hauser, C Schulte, I Csoti, T Gasser, D Berg Neurology 77 (3), 276-280, 2011 | 300 | 2011 |
| Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms C Blauwendraat, K Heilbron, CL Vallerga, S Bandres‐Ciga, R Von Coelln, ... Movement Disorders 34 (6), 866-875, 2019 | 289 | 2019 |
| GBA‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study K Brockmann, K Srulijes, S Pflederer, AK Hauser, C Schulte, W Maetzler, ... Movement Disorders 30 (3), 407-411, 2015 | 266 | 2015 |
| Using genome-wide complex trait analysis to quantify ‘missing heritability’in Parkinson's disease MF Keller, M Saad, J Bras, F Bettella, N Nicolaou, J Simón-Sánchez, ... Human molecular genetics 21 (22), 4996-5009, 2012 | 237 | 2012 |
| Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar, RH Reynolds, ... Nature genetics 53 (3), 294-303, 2021 | 216 | 2021 |
| Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis MA Van Es, HJ Schelhaas, PWJ Van Vught, N Ticozzi, PM Andersen, ... Annals of neurology 70 (6), 964-973, 2011 | 213 | 2011 |
| S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway K Sathe, W Maetzler, JD Lang, RB Mounsey, C Fleckenstein, HL Martin, ... Brain 135 (11), 3336-3347, 2012 | 211 | 2012 |
| Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics W Maetzler, I Liepelt, M Reimold, G Reischl, C Solbach, C Becker, ... Neurobiology of disease 34 (1), 107-112, 2009 | 204 | 2009 |
| Genetic basis of Parkinson’s disease: inheritance, penetrance, and expression C Schulte, T Gasser The application of clinical genetics, 67-80, 2011 | 196 | 2011 |
| Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ... Brain 143 (1), 234-248, 2020 | 181 | 2020 |
| Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis LF Burbulla, C Schelling, H Kato, D Rapaport, D Woitalla, C Schiesling, ... Human molecular genetics 19 (22), 4437-4452, 2010 | 162 | 2010 |
